Lymph Nodes News and Research

RSS

Danish researchers take an important step in finding a cure for HIV

For around 40 years, scientists all over the world have been unsuccessfully trying to find a cure for HIV, but now a team of researchers from Aarhus University and Aarhus University Hospital have apparently found an important element in the equation.

17 Oct 2022

Two cases of acute abdominal pain in patients with COVID-19 in their second week of illness

Researchers described two cases of acute pain in the abdomen of patients with COVID-19.

17 Oct 2022

Newly identified process keeps some immune cells on their toes

Cancer cells use an unusual mechanism to migrate into new tissue and form metastases there. The same process probably also keeps some immune cells on their toes.

14 Oct 2022

Multi-center analysis shines light on invasive lobular carcinoma

A multi-center analysis of patients with invasive lobular carcinoma, or ILC -; the second most common histological subtype of invasive breast cancer in the U.S. -; showed that, despite its prevalence, ILC is detected later and has worse outcomes than the predominant subtype of invasive breast cancer, known as invasive ductal carcinoma (IDC), or no special type.

14 Oct 2022

Study provides new insights into the origin and development of B cells

B cells and the antibodies they produce play an important role in our immune system, protecting us from the microscopic enemies that make us ill.

11 Oct 2022

The association of BNT16B2b2 mRNA COVID-19 vaccine with thrombocytopenia and pneumonitis: A case report

The case report of a patient who developed pneumonitis and thrombocytopenia concurrently after being administered the COVID-19 vaccine.

11 Oct 2022

The role of wastewater surveillance for monitoring monkeypox

A new study reviews the advantages and current challenges associated with wastewater-based surveillance of MPXV.

10 Oct 2022

Study links pancreatic cancer survival outcomes with arrangement of immune cells in tumors

Researchers from Johns Hopkins Medicine have discovered that the organization of different types of immune cells within pancreatic tumors is associated with how well patients with pancreatic cancer respond to treatment and how long they survive.

6 Oct 2022

Study reveals the determinants of persistent and severe COVID-19

As COVID-19 wreaks havoc across the globe, one characteristic of the infection has not gone unnoticed. The disease is heterogeneous in nature with symptoms and severity of the condition spanning a wide range.

5 Oct 2022

Study provides new insights into the underlying physiology of mevalonate kinase deficiency

A new study from the Garvan Institute of Medical Research shows how rises in core body temperature may trigger the inflammatory flares in people with a rare genetic autoinflammatory disease.

3 Oct 2022

Study looks at boosting with variant-derived COVID vaccine

In a recent study posted to bioRxiv*, researchers at Washington University School of Medicine, St. Louis, demonstrated that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine booster elicits robust germinal center (GC) B cell responses.

26 Sep 2022

Tumors generate unique, temporary cell-in-cell structures to evade immunotherapy

Scientists have shown how tumour cells evade immunotherapy by generating unique, temporary cell-in-cell structures, where the inner cells remain in tact and can return to single tumour cells.

20 Sep 2022

Research examines the roles of cytokines during SARS-CoV-2 infection in rhesus macaques

In a recent study posted to the bioRxiv* preprint server, researchers in the United States assessed the role of two cytokines, interferon-gamma (IFN-γ) and interleukin-10 (IL-10), in regulating immune cell responses and inflammation early during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in rhesus macaques.

18 Sep 2022

Single-cell RNA sequencing reveals dynamic immune landscape during the early stages of bubonic plague

This study is led by Dr. Ruifu Yang, Dr. Zongmin Du (State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology) and Dr. Fan Bai (Biomedical Pioneering Innovation Center, School of Life Sciences, Peking University).

16 Sep 2022

Study shows differences in treatment outcomes for Black vs. white women with hormone receptor-positive breast cancer

A study led by City of Hope, one of the largest cancer research and treatment organizations in the United States, found that Black women with Stage 1 or 2 breast cancer were almost three times more likely than white women to have tumor shrinkage from hormone therapy delivered prior to surgery, yet Black women were more likely than their white counterparts to have worse outcomes when this type of endocrine therapy before surgery was used at a later stage of disease.

16 Sep 2022

Study shows vaccine-derived poliovirus in infant with severe immunodeficiency

Researchers identified type 3 vaccine-derived poliovirus (VDPV) in an infant.

13 Sep 2022

The maternal and perinatal outcomes of pregnancies complicated by monkeypox infection

A new study reviews the available evidence on the impact of monkeypox infection during pregnancy.

13 Sep 2022

Study explores work experiences and quality of life for Hispanic survivors

As a cancer nurse in the U.S. Army for more than 29 years, Elizabeth Anderson saw firsthand how chemotherapy, radiation and surgeries impact the body's lymphatic system, putting breast cancer survivors at greater risk for developing lymphedema, a chronic condition of swelling that may occur after surgical removal, chemotherapy treatment, or irradiation of lymph nodes.

13 Sep 2022

Mucosal vaccination triggers superior T cell response against SARS-CoV-2 variants

In a recent study posted to the bioRxiv* server, researchers in Singapore and the United States demonstrated that intranasal (I.N.) delivery of a mucosal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination triggered a superior T cell response compared to an equivalent dose of antigen delivered by the subcutaneous (S.C.) route.

12 Sep 2022

N-dihydrogalactochitosan shows promise as a mucosal vaccine adjuvant against SARS-CoV-2

In a recent study posted to the bioRxiv* server, researchers in the United States demonstrated the efficacy of a novel biopolymer, N-dihydrogalactochitosan (GC), as an adjuvant for next-generation mucosal coronavirus disease 2019 (COVID-19) vaccine.

12 Sep 2022

Lymph Nodes News and Research

Danish researchers take an important step in finding a cure for HIV

Two cases of acute abdominal pain in patients with COVID-19 in their second week of illness

Newly identified process keeps some immune cells on their toes

Multi-center analysis shines light on invasive lobular carcinoma

Study provides new insights into the origin and development of B cells

The association of BNT16B2b2 mRNA COVID-19 vaccine with thrombocytopenia and pneumonitis: A case report

The role of wastewater surveillance for monitoring monkeypox

Study links pancreatic cancer survival outcomes with arrangement of immune cells in tumors

Study reveals the determinants of persistent and severe COVID-19

Study provides new insights into the underlying physiology of mevalonate kinase deficiency

Study looks at boosting with variant-derived COVID vaccine

Tumors generate unique, temporary cell-in-cell structures to evade immunotherapy

Research examines the roles of cytokines during SARS-CoV-2 infection in rhesus macaques

Single-cell RNA sequencing reveals dynamic immune landscape during the early stages of bubonic plague

Study shows differences in treatment outcomes for Black vs. white women with hormone receptor-positive breast cancer

Study shows vaccine-derived poliovirus in infant with severe immunodeficiency

The maternal and perinatal outcomes of pregnancies complicated by monkeypox infection

Study explores work experiences and quality of life for Hispanic survivors

Mucosal vaccination triggers superior T cell response against SARS-CoV-2 variants

N-dihydrogalactochitosan shows promise as a mucosal vaccine adjuvant against SARS-CoV-2

Immunology eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News